European Pharmaceutical Review

OCTOBER 30, 2023

Echoes of the global health challenges we faced during the COVID-19 pandemic still linger as new variants emerge and COVID continues to make headlines. A question that continues to sit in the back of many people’s minds is what happens if there is another outbreak or global pandemic? Are we preparing and how ready are we for the next one? Vaccitech’s Chief Business Officer, Graham Griffiths, discusses key learnings in drug and vaccine development , the challenges of preparing for the unknown, an

Vaccines 97

Vaccines Drug Development 97

STAT

NOVEMBER 3, 2023

More than 10 million people were disenrolled from Medicaid over the past six months, according to the latest data published by a KFF tracker. The tracker has collected data on Medicaid enrollment since the first states began redetermining eligibility in April, after the expiration of the federal requirement of continuous coverage during the Covid-19 public health emergency.

361

361

PharmaVoice

NOVEMBER 2, 2023

From Merck and J&J to AbbVie and Eisai, the oncology field has stayed consistently devoted to churning out important therapies.

265

265

ALiEM - Pharm Pearls

NOVEMBER 3, 2023

Welcome to the AIR Trauma Module! After carefully reviewing all relevant posts in the past 12 months from the top 50 sites of the Digital Impact Factor [1], the ALiEM AIR Team is proud to present the highest quality online content related to related to trauma in the Emergency Department. 8 blog posts met our standard of online excellence and were approved for residency training by the AIR Series Board.

Labelling 209

Labelling 209

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

BioPharma Dive

OCTOBER 31, 2023

The high-profile meeting focused on the theoretical risks of CRISPR gene editing, as both the FDA and its advisory committee appeared convinced by the efficacy of the companies’ exa-cel treatment.

132

132

STAT

OCTOBER 31, 2023

Nearly six weeks after his surgery, the world’s second recipient of a genetically modified pig heart has died, the University of Maryland announced Tuesday. Lawrence Faucette, a 58-year-old resident of Frederick, Md., with terminal heart disease, died Monday. He had received the experimental xenotransplant on September 20 at the University of Maryland Medical Center in an eight-hour operation.

363

363

ALiEM - Pharm Pearls

NOVEMBER 1, 2023

What clinical presentation and medication is associated with this urinary discoloration? Critical illness requiring intubation and propofol sedation Cyanide toxicity requiring sodium thiosulfate Iron toxicity treated with deferoxamine Refractory vasoplegic shock treated with methylene blue Septic shock treated with vancomycin and cefepime Reveal the Answer 3.

Clinical Pharmacology 158

Clinical Pharmacology Dosage Compounding 158

BioPharma Dive

OCTOBER 31, 2023

Expert advisers are reviewing the companies’ case for approval of what could be the first medicine based on the gene editing technology. Follow their discussion here.

129

129

STAT

OCTOBER 31, 2023

Editor’s note: This essay contains spoilers for the Netflix show “The Fall of the House of Usher.” “W atch “ The Fall of the House of Usher” on Netflix when you can. F**cking Great! Totally based on the Sacklers—Fictional obviously but so damn good!

362

362

PharmaVoice

NOVEMBER 1, 2023

From hallucinations to data privacy, pharma looks to iron out the kinks of generative AI.

289

289

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

The Pharmacist

OCTOBER 30, 2023

The General Pharmaceutical Council (GPhC) has extended the revalidation deadline, giving pharmacists due to submit their revalidation by 31 October an extra week to do so, following technical issues with its website. Pharmacists that were due to revalidate by the end of October now have until 11:59pm on Tuesday 7 November 2023 to submit their […] The post Revalidation deadline extended after GPhC technical issues appeared first on The Pharmacist.

122

122

BioPharma Dive

NOVEMBER 3, 2023

The company recorded a net loss in the third quarter as it “resizes” its manufacturing footprint, and now expects revenue to come in at low end of its previous guidance.

Vaccines 120

Vaccines 120

STAT

NOVEMBER 2, 2023

A bipartisan group of senators this week introduced a bill that would permanently allow health providers to prescribe buprenorphine , a common medication used to treat opioid addiction, via telehealth. The measure, known as the Telehealth Response for E-prescribing Addiction Therapy Services Act — TREATS, for short — would permanently extend a temporary, Covid-era policy that allowed patients to receive buprenorphine remotely, without an in-person visit.

356

356

PharmaVoice

OCTOBER 31, 2023

Roivant CEO Matt Gline and Telavant CEO Frank Torti know Roivant’s position as buyers and sellers in the pharma industry, and they’re embracing those opportunities.

174

174

The Pharmacist

NOVEMBER 3, 2023

Pharmacists have called for greater awareness of the profession after an MP appeared to mistakenly refer to the profession as ‘pharmacologists’ on BBC Question Time last night. Member of Parliament for Horsham and Cabinet Office minister Jeremy Quin highlighted the roles of ‘pharmacologists’ working in general practice in response to a comment made by a […] The post Pharmacists call for greater awareness following Question Time comment appeared first on The Pharmacist.

118

118

Pharmafile

NOVEMBER 1, 2023

AstraZeneca has announced a collaboration and investment agreement with Cellectis for the development of next generation cell and gene therapeutics (CGTs) in areas such as oncology, immunology and rare diseases. Under terms of this agreement, AstraZeneca will utilise Cellectis’ proprietary gene editing technologies and manufacturing capabilities with the intention of designing novel CGT products. 25 […] The post AstraZeneca and Cellectis to collaborate for cell therapy and genomic medicine

115

115

STAT

NOVEMBER 1, 2023

Most lung cancer screening guidelines hinge on how much people smoked tobacco and when they last smoked, but the American Cancer Society now says it doesn’t matter how long ago they quit. On Wednesday, the ACS released guidance recommending that anyone with a significant smoking history get an annual low-dose CT scan for lung cancer. The new guidelines also expand the age range for lung cancer screening to 50 through 80, instead of 55 through 74, and lower the smoking history requirement

355

355

PharmaVoice

NOVEMBER 2, 2023

A challenging funding environment and lack of partnering deals have contributed to the market's ongoing troubles.

174

174

Pharma Times

NOVEMBER 3, 2023

Since 2022, an estimated 17,000 strokes and 4,000 deaths have been prevented - News - PharmaTimes

146

146

Drug Patent Watch

OCTOBER 30, 2023

Over the past two decades, Bayer Pharma has developed an in silico absorption, distribution, metabolism, and excretion (ADMET) platform with the aim of generating models for various pharmacokinetic and physicochemical… The post Advancements in In Silico ADMET Modeling: A 20-Year Journey of Machine Learning in Drug Discovery at Bayer Pharma appeared first on DrugPatentWatch - Make Better Decisions.

111

111

STAT

NOVEMBER 2, 2023

Our minds have a weird and wondrous way of transporting us to other places and times. You might find yourself, for instance, immersed in the vivid world of a novel, or reminiscing about a potluck with close friends. These reveries can feel magical, but they’re the result of complex electric signals zipping through the brain. Now a new study shows we’re not the only ones with an imagination.

354

354

Express Pharma

OCTOBER 30, 2023

Suven Life Sciences announced positive topline results from its Phase-2 proof-of-concept study assessing the safety and efficacy of Samelisant for the treatment of excessive daytime sleepiness (EDS) in adult narcolepsy patients with and without cataplexy. The study met primary endpoint, with Samelisant demonstrating statistically significant and clinically meaningful reduction in EDS measured by the ESS total score compared to placebo at Day 14 (p<0.05).

110

110

Pharma Times

OCTOBER 31, 2023

Around 400,000 eligible patients are set to benefit from the travel offer - News - PharmaTimes

146

146

Drug Patent Watch

OCTOBER 30, 2023

Annual Drug Patent Expirations for CALQUENCE Calquence is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eight patents protecting… The post New patent for Astrazeneca drug CALQUENCE appeared first on DrugPatentWatch - Make Better Decisions.

111

111

STAT

OCTOBER 30, 2023

When the human body is exposed to extreme heat, it tries to fight back. To keep us from cooking, our hearts pump faster and harder to distribute the hot blood out to our fingers and toes, away from precious internal organs. We produce more sweat, and when it evaporates, the blood beneath the skin’s surface cools down, helping to lower our body temperature.

352

352

The Pharmacist

OCTOBER 31, 2023

A new chief pharmacy officer and deputy registrar has been appointed at the General Pharmaceutical Council (GPhC) to help provide pharmacy leadership across the organisation and ‘influence progress at an exciting and challenging time’ for the profession. Roz Gittins has been announced as the new chief pharmacy officer and deputy registrar of the GPhC, while […] The post GPhC announces new executive appointees appeared first on The Pharmacist.

107

107

Express Pharma

NOVEMBER 1, 2023

In September this year, Alkem Laboratories sharpened focus on its API business, branding it as Alkem Activa. Promoter-MD Sandeep Singh’s ambition “to propel Alkem Activa into the forefront of the API market” no doubt echoes the sentiments of many API contract manufacturers in India. The logic is simple. API makers across the world are rebounding from COVID-related disruptions in 2020.

106

106

PharmaTech

NOVEMBER 2, 2023

Pharmaceutical Technology Europe® speaks with Joren van der Horst from Luo Automation, a Dutch company focused on automated visual inspection solutions, at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023.

105

105

STAT

OCTOBER 29, 2023

My husband’s cancer came back this summer after not being evident for almost two years. With advances in cancer surveillance, we now speak of cancer survivors being cancer-free far less frequently. If you are among the luckiest unlucky who survive treatment for metastatic cancer and receive clear scans, you simply have “no evidence of disease.

349

349

Drug Patent Watch

OCTOBER 30, 2023

Annual Drug Patent Expirations for REMODULIN Remodulin is a drug marketed by United Therap and is included in two NDAs. It is available from one supplier. There are ten patents… The post New patent for United Therap drug REMODULIN appeared first on DrugPatentWatch - Make Better Decisions.

105

105

Express Pharma

NOVEMBER 1, 2023

Dr Reddy’s Laboratories announced that the Science Magazine has ranked the company among its Top 20 Employers list in pharma, biotechnology and biopharma for 2023 for the second year in a row. Based in the United States, Science is the peer-reviewed academic journal of the American Association for the Advancement of Science (AAAS) and one of the world’s top academic journals.

105

105

Med Ed 101

OCTOBER 29, 2023

How many times have you picked up, dispensed, or seen an auxiliary label on a medication encouraging you to avoid alcohol while taking it? It’s definitely information that could come up on a board exam at some point throughout your career! Below is a table listing the top 5 alcohol and medication interactions. These 5 […] The post Top 5 Alcohol and Medication Interactions appeared first on Med Ed 101.

Labelling 105

Labelling 105

STAT

NOVEMBER 1, 2023

The U.S. infant mortality rate rose 3% last year — the largest increase in two decades, according to the Centers for Disease Control and Prevention. White and Native American infants, infant boys and babies born at 37 weeks or earlier had significant death rate increases. The CDC’s report, published Wednesday, also noted larger increases for two of the leading causes of infant deaths — maternal complications and bacterial meningitis.

343

343

Drug Patent Watch

OCTOBER 31, 2023

Annual Drug Patent Expirations for CALQUENCE Calquence is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eight patents protecting… The post New patent for Astrazeneca drug CALQUENCE appeared first on DrugPatentWatch - Make Better Decisions.

104

104

Express Pharma

NOVEMBER 3, 2023

The pharma sector is slowly shedding its image as a digital laggard. The jolt from the COVID pandemic saw many companies hasten their digital transformation journey. Many of the early birds are tasting the low-hanging fruits of these forays. But a lot still needs to be done to truly catch up with other sectors. So what are the best practices and learnings of these pharma digital torchbearers?

Packaging 104

Packaging Dosage Communication 104